معرفی
Jared R. Auclair serves as Dean of the College of Professional Studies and Professor in the Department of Chemistry and Chemical Biology at Northeastern University, with additional affiliations at the Barnett Institute for Chemical and Biological Analysis. His leadership portfolio includes former roles as Vice Provost of Research Economic Development, Director of Bioinnovation, and Associate Dean of Professional Programs and Graduate Affairs at the College of Science.
Dr. Auclair's research program centers on work-integrated credentialed learning and use-inspired biopharmaceutical research, emphasizing cross-sector collaboration between academia, industry, and government. His expertise spans analytical characterization of therapeutics, regulatory science, and development of training platforms for biopharmaceutical workforce development, with recent focus on AI integration and virtual reality applications for drug quality assurance.
Analysis of his recent publications reveals a dominant trend in applying advanced analytical techniques—particularly mass spectrometry and chromatography—to biopharmaceutical characterization challenges, with growing emphasis on AI-driven solutions for regulatory compliance, gene therapy analysis, and pandemic response tools. His work bridges fundamental science with industry applications across therapeutic proteins, cannabis analysis, and viral vector characterization.
Dr. Auclair mentors graduate students through the Biopharmaceutical Analysis Training Laboratory, which partners with industry leaders like Agilent to develop virtual reality training modules and secure collaborative projects with institutions including Loyalist College in Canada for cannabis regulatory analysis. His leadership has established frameworks for STEM education platforms addressing smart biopharmaceutical manufacturing and drug shortage mitigation.
The Biopharmaceutical Analysis Training Laboratory operates as an innovation hub for analytical science, featuring collaborations with Agilent on virtual reality drug quality systems and with Canadian institutions on cannabis product analysis. Current initiatives focus on training the next generation of scientists in regulatory-compliant analytical techniques while addressing emerging market challenges in biopharmaceuticals.
